Joaquim Carreras
Overview
Explore the profile of Joaquim Carreras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1019
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katagiri S, Akahane D, Takeyama K, Sato N, Takayama N, Ando J, et al.
Ann Hematol
. 2025 Mar;
PMID: 40059232
In most cases of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma (ALK + ALCL), long-term survival is achieved using CHOP therapy. However, some cases have a poor prognosis. Here, we...
2.
Carreras J, Roncador G, Hamoudi R
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766129
Background: Ulcerative colitis is a chronic inflammatory bowel disease of the colon mucosa associated with a higher risk of colorectal cancer. Objective: This study classified hematoxylin and eosin (H&E) histological...
3.
Endo S, Nishimura N, Toyoda K, Komohara Y, Carreras J, Yuki H, et al.
Cancer Sci
. 2024 Sep;
115(12):3890-3901.
PMID: 39321027
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma, accounting for 30% of non-Hodgkin lymphomas. Although comprehensive analysis of genetic abnormalities has led to the classification of...
4.
Carreras J
J Imaging
. 2024 Aug;
10(8).
PMID: 39194989
Celiac disease (CD) is a gluten-sensitive immune-mediated enteropathy. This proof-of-concept study used a convolutional neural network (CNN) to classify hematoxylin and eosin (H&E) CD histological images, normal small intestine control,...
5.
Yanagiya R, Miyatake Y, Watanabe N, Shimizu T, Kanamori A, Ueno M, et al.
Leukemia
. 2024 Jun;
38(8):1731-1741.
PMID: 38914715
Aggressive natural killer cell leukemia (ANKL) is a rare hematological malignancy with a fulminant clinical course. Our previous study revealed that ANKL cells proliferate predominantly in the liver sinusoids and...
6.
Mashiko T, Carreras J, Ogasawara T, Masuoka Y, Ei S, Takahashi S, et al.
Surgery
. 2024 May;
176(2):259-266.
PMID: 38796389
Background: This single-center retrospective study aimed to clarify the clinical and pathologic background of mass-forming intrahepatic cholangiocarcinomas. Methods: A total of 53 patients with mass-forming intrahepatic cholangiocarcinomas were selected from...
7.
Carreras J, Hamoudi R, Nakamura N
Explor Target Antitumor Ther
. 2024 May;
5(2):332-348.
PMID: 38745770
Hematologists, geneticists, and clinicians came to a multidisciplinary agreement on the classification of lymphoid neoplasms that combines clinical features, histological characteristics, immunophenotype, and molecular pathology analyses. The current classification includes...
8.
Kudo K, Yanagiya R, Hasegawa M, Carreras J, Miki Y, Nakayama S, et al.
Cell Death Discov
. 2024 May;
10(1):221.
PMID: 38719806
Lipid-mediated inflammation is involved in the development and malignancy of cancer. We previously demonstrated the existence of a novel oncogenic mechanism utilizing membrane lipids of extracellular vesicles in Epstein-Barr virus...
9.
Carreras J, Ikoma H, Kikuti Y, Miyaoka M, Hiraiwa S, Tomita S, et al.
Virchows Arch
. 2024 Mar;
484(4):657-676.
PMID: 38462571
BCL6-rearrangement (BCL6-R) is associated with a favorable prognosis of follicular lymphoma (FL), but the mechanism is unknown. We analyzed the clinicopathological, immune microenvironment (immune checkpoint, immuno-oncology markers), and mutational profiles...
10.
Suma S, Suehara Y, Fujisawa M, Abe Y, Hattori K, Makishima K, et al.
Leukemia
. 2023 Nov;
38(2):340-350.
PMID: 38012392
T follicular helper (T) cell lymphomas (TFHLs) are characterized by T-like properties and accompanied by substantial immune-cell infiltration into tumor tissues. Nevertheless, the comprehensive understanding of tumor-cell heterogeneity and immune...